Medical Minute 2: Current and Emerging Therapies for Advanced NSCLC With HER2 Mutations and HER2 Overexpression

Medical Minute 2: Current and Emerging Therapies for Advanced NSCLC With HER2 Mutations and HER2 Overexpression

Watch this video to gain expert insights on current and emerging treatment options for patients with advanced nonsmallcell lung cancer and HER2 alterations

  • Provider:Clinical Care Options
  • Activity Link: https://clinicaloptions.com/CE-CME/oncology/nsclc-her2-alterations-therapies/25338-56572
  • Start Date: 2024-10-18 05:00:00
  • End Date: 2024-10-18 05:00:00
  • Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
  • Commercial Support: Source: Boehringer Ingelheim Pharmaceuticals, Inc. - Amount: 50000.0 - Is Kind Support: False
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner Knowledge, Learner/Team Competence
  • Provider Ship: Directly Provided
  • Registration: Open to all
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.